Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have been a big supporter of Dan over the years. Saying he has done a great job turning the company around but if things don't start to change soon as shareholders we need to come together and find away to have Dan move on. I still think one of the biggest problems is he took our lead product and made small non-cash positive deals all over the world in some of the largest markets instead of selling it all to one company for upfront cash and worldwide rights. Most of you still post every day like nothing has changed. Most of the trials we have ongoing are taking way to long and others are taking to long to start. I can only hope they have something hidden up their sleeve or this is going to be a long/ugly 2017
I guess this is the new level we will be stuck at. How pathetic!!!! I have extra cash to add but can honestly say for the first time I'm scared to do that. Wow who thought we would be sitting at this pps/MC right now.
Let me save you another phone call because all they are going to tell you is they have cash until 2019. What would be nice to know. Is there a milestone payment for start of NEO phase 1 and if so how much is it?
No you're not
I'm not saying Advaxis got dumped by Astra but it clearly states in the webcast they chose BMY. I'm getting tired of hearing the excuse that no upfront money was given because BMY is providing OPDIVO. If they truly believed like Amgen did then they would be looking for a stronger agreement before starting the phase 3. Which would be much cheaper for them now rather then later
According to James Salmon
"Okay just spoke with company, I will keep this short;
Astra Combo trial is continuing as planned, and nothing negative should be reflected from them not being included on slide 4.
Advaxis plan has always been to partner with multiple players and Advaxis feels that they have done this in the PD1 space.
So there you go, all is well."
How low will we GO!! So someone that actually knows what is going on. Please explain!! The steady increase in volume is what interest me but I have no idea if it's a good thing or bad. Things seem to be going well at the company and they have their hands full but all these things take TIME!!!! So what's up with the increase in volume and will they continue to pound the pps down over the next few months
Zzzzzzzzzzzzzzzzzzzzz
19:40 to 21:00 he talks about Durvalumab but then says Merck not Astra and even talks about the CR the study had
So if you listen to the webcast starting around 19:00 Dan is explaining why they chose BMY and not Astra but it gets confusing because he says Merck but I'm pretty sure he ment Astra. Please let me know if anyone else hears what I did between 19 to 21 minutes in
One thing seems to be for sure. They were deliberately left out of slide #4. If it was a mistake(which I don't think is the case) that would be just so embarrassing!!!!
Fbg, it could be! It's either that or the opposite. Time will tell.
Well we know they had a CR right out the gate and I don't think BMY would want to combo with us on a phase 3 if they didn't see some proof of concept. I would just think maybe Astra was playing hardball so Dan is possibly going different road
If you listen to the webcast Dan mentions Astra I think once but talks about all the other partners throughout the whole presentation
Ok look at slide 4 and tell me that Astra not being mentioned isn't a little odd. I think they are on the way out and being replaced by BMY
Do you find it strange???? That Astra wasn't really mentioned at all. Dan talked about all the other collaborations several times. I think Astra is out and BMY is in now or maybe Astra will be the next big partner. It sounded has if they have a partner for ADXS-HOT, just my thoughts
This push upwards is different than the ones in the past. Let's see if it holds going into end of day but definitely a strong move up
Looking forward to June 12th
"Clinical Trial Update with Case Study Highlights
Plans for Data Dissemination and Timelines
Update on Advaxis’ Corporate Collaborations
Research Update on the NEO and HOT Programs
Progress Towards Regulatory Submission and Commercial Readiness"
So Advaxis was scheduled to present at Jefferies health care conference this week. They haven't PR'd it yet. Which could come tomorrow or later this week but it's also not listed under upcoming events. Hoping they don't attend and are busy working on another deal.
Ok sure!!! Really don't care, have a great day
You change your predictions like a normal person changes their underwear but best of luck to you
I would just like to see updates on all trials at investor day. That would help!!
Wow they have a booth!!! Looks like INCY stole the show this year. Hopefully we get updates later this year from the Astra combo trial and the Merck combo trial
I didn't give the deal enough credit either that day. Thats why I kept saying it didn't make sense but to start as a phase 3 would be awesome!! Still need FDA approval but with BP behind you much easier to get
Everyone keeps talking buyout but I don't think Dan's intentions are to sell or at least not for a while. I believe he's looking build something to keep.
Advaxis loves keeping their website fresh and new, check it out. Nice to see they keep on top of it
Great news this morning!!!!
Omg James thank you so much for clarifying that for me and everyone else.
I know isn't that what I said
I think Dan has done a good job. Not great but good and he gets paid enough to be able to afford 25% of his salary to purchase shares. The BIG thing for me is that he has not sold any shares. The question I would ask is why has no one new been added to this monthly purchase plan. They have brought in plenty of big talent but nobody else is buying shares except the original 4(I believe) Dan, Robert, Sara and Greg(who is no longer here). The whole buy shares monthly in my eyes was part of there salary when they negotiated it but once again it's nice to see that they don't sale on a regular basis
I don't think it's because AXAL doesn't work. I think it's because Dan already gave away a large part of the cervical market to smaller pharma companies. Look at the Amgen deal. They own the rights to all of it worldwide.
At this point the deal really doesn't make sense to me unless Astra and Advaxis are parting ways. Which I hope it isn't the case or Astra isn't willing to pay the amount Dan is looking for so he decided to send a message and say we now have other options
Ok so starting all over again. So what happens with Astra going forward? We were working on combo for cervical cancer with them and it sounded like things were going well. Also look at BMY news we are not the only company they collaborated with this AM
Once again something nobody saw coming. Don't real get the deal. We were going to start a phase 3 trial for metastatic cervical cancer later this year but there is no mention of that in the PR. Definitely not the deal I was looking for. Going to be a long year at this rate
Understood, thanks
Also check out INO's volume. That's the kind of volume we will see when we get real news
Omg FBG if a deal does come please don't say I told you so, lol. You have been saying it for at least 6 months now!!!!!!! Once again even a broken clock is right twice a day. I love that we broke through $9 but if you look back at a three month chart. We broke through and reached about $9.60 twice. So don't get to excited yet.
ADXS closed at $8.68 yesterday, Bam
Good point, Fbg
I am a Pro Trader the pps will go up-down and down-up today. Watch an learn, lol